Senior Clinical Trial Associate (Sr. CTA)
- Employer
- Nurix Therapeutics
- Location
- Brisbane, California
- Posted date
- Sep 28, 2026
View more categories
- Discipline
- Clinical, Clinical Research, Clinical Trials
- Required Education
- Bachelors Degree
- Position Type
- Full time
By clicking apply, your email address will be shared with the employer.
Job Details
Senior Clinical Trial Associate (Sr. CTA) NX-1607
You’ve done this before — now do it with more ownership. You’ll run the TMF for your studies end-to-end, work directly with CROs to resolve problems before they become problems, and help the CTAs around you get better at the job.
Position Description
You’ll independently own key operational pieces of our trials — from TMF integrity to vendor coordination — and mentor junior team members along the way.
The Opportunity
Own the study TMF plan end-to-end: development, tracking, and archiving of Essential Documents across the trial lifecycle
Lead quality reviews of the TMF and resolve discrepancies directly with the CRO
Draft and finalize study documents — plans, manuals, CRFs, and patient materials — with minimal oversight
Serve as a go-to resource for junior CTAs, providing informal mentorship and process guidance
Independently manage clinical supply and lab sample coordination, flagging risks before they escalate
Own data reconciliation issues across systems, looping in Data Management only when needed
Represent Clinical Operations at portions of team meetings and Investigator Meetings
Help shape training materials and SOPs used across the broader CTA team
What You’ll Bring
Bachelor’s degree (BS/BA) or equivalent combination of education and work experience in a science-related field
3–5+ years of Clinical Operations or clinical research-related experience
Demonstrated ownership of a TMF or vendor relationship from start to finish
Comfortable resolving routine CRO/vendor issues independently before escalating
Experience mentoring or informally guiding junior team members
Excellent verbal and written communication skills
Proficiency with MS Word, Excel, Outlook, and PowerPoint
Salary Range: $134,500 - $146,600 annually
The posted range applies to roles based in the San Francisco Bay Area and reflects local market conditions. Where an offer lands within that range depends on the candidate’s relevant experience, technical expertise, and how their background aligns with the role’s requirements.
Location: Onsite - Brisbane, CA
Fit with Nurix Culture and Values
Strong team orientation; highly collaborative
Solutions and results-oriented focus
Hands-on approach; resourceful and open to diverse points of view
About Nurix Therapeutics
Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases. Powered by a fully AI-integrated discovery engine capable of tackling any protein class, and coupled with unparalleled ligase expertise, Nurix’s dedicated team has built a formidable advantage in translating the science of targeted protein degradation into clinical advancements. Nurix aims to establish degrader-based treatments at the forefront of patient care, writing medicine’s next chapter with a new script to outmatch disease.
Company
Nurix Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. Leveraging Nurix’s extensive expertise in E3 ligases together with its proprietary DNA-encoded libraries, Nurix has built DELigase, an integrated discovery platform to identify and advance novel drug candidates targeting E3 ligases, a broad class of enzymes that can modulate proteins within the cell. Nurix’s drug discovery approach is to either harness or inhibit the natural function of E3 ligases within the ubiquitin proteasome system to selectively decrease or increase cellular protein levels.
Nurix’s wholly owned pipeline comprises targeted protein degraders of Bruton’s tyrosine kinase, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, an E3 ligase that regulates T cell activation. Nurix is headquartered in San Francisco, California.
- Phone
- 415-660-5320
- Location
- 1700 Owens Street
Suite 205
San Francisco
California
94158